Firma en Digital.CSIC (*)
Chioua, Mourad
 
Centro o Instituto
CSIC - Instituto de Quimica Organica General (IQOG)
 
Departamento
Síntesis, Estructura y Propiedades de Compuestos Orgánicos (SEPCO)
 
Especialización
Química Médica
 
Email
m.chioua@csic.es
 
 
Perfil en Google Scholar
 
WoS ResearcherID - Publons
 
Scopus AuthorID
 
Otros - ResearchGate
 

Publications

Results 1-20 of 38 (Search time: 0.028 seconds).

RightsPreviewIssue DateTitleAuthor(s)Type
1openAccessWO2011051527A1.pdf.jpg5-May-20111,8-Naphthyridine-devired compounds and the use thereof in the treatment of neurodegenerative diseasesRíos Salgado, Cristóbal; Romero Martínez, Alejandro; Egea Maiquez, Javier; León, Rafael ; Villarroya Sánchez, Mercedes; García López, Manuela; García García, Antonio; Marco-Contelles, José CSIC ORCID; Soriano, Elena CSIC; Samadi, Abdelouahid CSIC ORCID; Chioua, Mourad CSIC ORCID artículo
2closedAccessaccesoRestringido.pdf.jpg20175-Amino-6,7,8,9-Tetrahydrobenzo[b][1,8]Naphthyridin-2(1H)-One: The first Example of a new Family of HuperTacrines for Alzheimer's Disease TherapyBalmori, Alfonso; Chioua, Mourad CSIC ORCID ; Bellacasa, R. P. de la; Estrada-Tejedor, R.; Ismaili, Lhassane; Marco-Contelles, José CSIC ORCID; Borrell, J. I.artículo
3closedAccessaccesoRestringido.pdf.jpg2011A practical two-step synthesis of imidazo[1,2-a]pyridines from N-(prop-2-yn-1-yl)pyridin-2-aminesSucunza, D.; Samadi, Abdelouahid CSIC ORCID; Chioua, Mourad CSIC ORCID ; Silva, Daniel; Yunta, C.; Infantes, L. CSIC ORCID; Carmo Carreiras, M.; Soriano, Elena CSIC; Marco-Contelles, José CSIC ORCIDartículo
4closedAccessaccesoRestringido.pdf.jpg2017A Simple and Ecofriendly One-Pot Synthesis of Highly Substituted 3-Cyanopyridine-Quinoline Hybrids via a Triphenyphosphine-Catalyzed Multicomponent Reaction Under Mild ConditionsLadraa, S; Chioua, Mourad CSIC ORCID ; Belfaitah, A.artículo
5closedAccessaccesoRestringido.pdf.jpg2020Automated Synthesis of New QuinoxalinetacrinesBautista-Aguilera, Óscar M.; Ismaili, L.; Chioua, Mourad CSIC ORCID ; Iriepa, Isabel; Martínez-Grau, Angeles; Beadle, C. D.; Vetman, T.; López-Muñoz, Francisco; Marco-Contelles, José CSIC ORCIDartículo
6openAccesscholesteroNitrone_drug_treatment_ischemic_stroke.pdf.jpg31-Mar-2020Characterization of a cholesteroNitrone (ISQ-201), a novel drug candidate for the treatment of ischemic strokeMartínez-Alonso, Emma; Escobar-Peso, Alejandro; Ayuso, María I.; Gonzalo-Gobernado, Rafael; Chioua, Mourad CSIC ORCID ; Montoya, Juan J.; Montaner, Joan; Fernández, Israel; Marco-Contelles, José CSIC ORCID; Alcázar, Albertoartículo
7closedAccessaccesoRestringido.pdf.jpg2015CholesteroNitrones for StrokeAyuso, M. I.; Chioua, Mourad CSIC ORCID ; Martínez-Alonso, E.; Soriano, Elena CSIC; Montaner, Joan; Masjuán, J.; Hadjipavlou-Litina, Dimitra; Marco-Contelles, José CSIC ORCID; Alcázar, Albertoartículo
8closedAccessaccesoRestringido.pdf.jpg2015Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer’s diseaseChioua, Mourad CSIC ORCID ; Pérez, Marta M.; Bautista-Aguilera, Óscar M.; Yáñez, M.; López, M. G.; Romero, A.; Cacabelos, Ramón; Bellacasa, R. P. de la; Brogi, S.; Butini, S.; Borrell, J. I.; Marco-Contelles, José CSIC ORCIDartículo
9openAccessmolecules-21-00400.pdf.jpg24-Mar-2016Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer's Disease TherapyBoulebd, Houssem; Ismaili, L.; Bartolini, Manuela; Bouraiou, Abdelmalek; Andrisano, Vincenza; Martin, Hélène; Bonet, Alexandre; Moraleda, Ignacio; Iriepa, Isabel; Chioua, Mourad CSIC ORCID ; Belfaitah, Ali; Marco-Contelles, José CSIC ORCIDartículo
10closedAccessaccesoRestringido.pdf.jpg2015Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's diseaseCherif, O.; Allouche, F.; Chabchoub, Fakher; Chioua, Mourad CSIC ORCID ; Soriano, Elena CSIC; Yáñez, Matilde; Cacabelos, Ramón; Romero, A.; López, M. G.; Marco-Contelles, José CSIC ORCIDartículo
11closedAccessaccesoRestringido.pdf.jpg2015α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: Synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability propertiesChioua, Mourad CSIC ORCID ; Sucunza, D.; Soriano, Elena CSIC; Hadjipavlou-Litina, Dimitra; Alcázar González, Alberto; Ayuso, I.; Oset-Gasque, María J.; Gonzalez, M. P.; Monjas, Leticia CSIC ORCID; Rodríguez-Franco, María Isabel CSIC ORCID ; Marco-Contelles, José CSIC ORCID; Marco-Contelles, José CSIC ORCID; Samadi, Abdelouahid CSIC ORCIDartículo
12openAccessDrug Design, Development and Therapy.pdf.jpg2014Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease: Design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybridsBautista-Aguilera, Óscar M.; Esteban, Gerard; Chioua, Mourad CSIC ORCID ; Nikolic, Katarina; Agbaba, Danica; Moraleda, Ignacio; Iriepa, Isabel; Soriano, Elena CSIC; Samadi, Abdelouahid CSIC ORCID; Unzeta, Mercedes; Marco-Contelles, José CSIC ORCIDartículo
13closedAccessaccesoRestringido.pdf.jpg2017Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3R Antagonism for Neurodegenerative DiseasesBautista-Aguilera, Óscar M.; Hagenow, S.; Palomino-Antolin, A.; Farré-Alins, V.; Ismaili, L.; Joffrin, P. L.; Jimeno, M. Luisa; Soukup, O.; Janockova, Jana; Kalinowski, A.; Proschak, E.; Iriepa, Isabel; Moraleda, I.; Schwed, J. S.; Romero Martínez, Alejandro; López-Muñoz, Francisco; Chioua, Mourad CSIC ORCID ; Egea, Javier; Ramsay, R. R.; Marco-Contelles, José CSIC ORCID; Stark, H.artículo
14closedAccessaccesoRestringido.pdf.jpg2014N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA): A potential cognitive enhancer with MAO inhibitor propertiesDi Giovanni, Giuseppe; García, Isela; Colangeli, Roberto; Pierucci, Massimo; Rivadulla, Marcos L.; Soriano, Elena CSIC; Chioua, Mourad CSIC ORCID ; Della Corte, Laura; Yáñez, Matilde; De Deurwaerdère, Phillippe; Fall, Yagamare; Marco-Contelles, José CSIC ORCIDartículo
15closedAccessaccesoRestringido.pdf.jpg2014N-methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitorBautista-Aguilera, Óscar M.; Samadi, Abdelouahid CSIC ORCID; Chioua, Mourad CSIC ORCID ; Nikolic, K.; Filipic, S.; Agbaba, Danica; Soriano, Elena CSIC; Andrés, L. de; Rodríguez-Franco, María Isabel CSIC ORCID ; Alcaro, S.; Ramsay, R. R.; Ortuso, F.; Yáñez, Matilde; Marco-Contelles, José CSIC ORCIDartículo
16closedAccessaccesoRestringido.pdf.jpg2017New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer diseaseBoulebd, Houssem; Ismaili, L.; Martin, H.; Bonet, A.; Chioua, Mourad CSIC ORCID ; Marco-Contelles, José CSIC ORCID; Belfaitah, A.artículo
17closedAccessaccesoRestringido.pdf.jpg2019New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective (Z)- N- tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke TreatmentChioua, Mourad CSIC ORCID ; Martínez-Alonso, Emma; Gonzalo-Gobernado, Rafael; Ayuso, María I.; Escobar-Peso, A.; Infantes, L. CSIC ORCID; Hadjipavlou-Litina, Dimitra; Montoya, Juan J.; Montaner, Joan; Alcázar, Alberto; Marco-Contelles, José CSIC ORCIDartículo
18closedAccessaccesoRestringido.pdf.jpg2019Novel Quinolylnitrones Combining Neuroprotective and Antioxidant PropertiesChioua, Mourad CSIC ORCID ; Salgado-Ramos, M.; Diez-Iriepa, D.; Escobar-Peso, A.; Iriepa, Isabel; Hadjipavlou-Litina, Dimitra; Martínez-Alonso, Emma; Alcázar, Alberto; Marco-Contelles, José CSIC ORCIDartículo
19closedAccessaccesoRestringido.pdf.jpg2016Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's diseaseGarcía-Font, N.; Hayour, H.; Belfaitah, A.; Pedraz, J.; Moraleda, I.; Iriepa, Isabel; Bouraiou, A.; Chioua, Mourad CSIC ORCID ; Marco-Contelles, José CSIC ORCID; Oset-Gasque, M. J.artículo
20openAccesspharmaceuticals-14-00861-v2.pdf.jpg2021Privileged quinolylnitrones for the combined therapy of ischemic stroke and alzheimer’s diseaseAlonso, José M. CSIC; Escobar-Peso, A.; Palomino-Antolín, A.; Diez-Iriepa, Daniel; Chioua, Mourad CSIC ORCID ; Martínez-Alonso, E.; Iriepa, I.; Egea, J.; Alcázar, A.; Marco-Contelles, José CSIC ORCIDartículo